Omnicell OMCL 深 沪
等待开盘 08-18 09:30:00 美东时间
35.91
-1.390
-3.73%
华盛通- 最 高37.08
- 今 开36.85
- 成交量 44.45万股
- 最 低 35.76
- 昨 收 37.30
- 总市值 16.38亿
- 52周最高 55.00
- 市盈率 静 810.61
- 换手率 0.97%
- 52周最低 29.06
- 委 比 -5.12%
- 总股本 4561.49万
- 历史最高 187.285
- 量 比 1.53
- 振 幅 3.54%
- 历史最低 12.33
- 每 手 1
- 风险率 5.84%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多U.S. Physical Therapy names Nchacha Etta as CFO
U.S. Physical Therapy (USPH) said Nchacha Etta will become executive vice president and chief financial officer effective Sept. 1, succeeding Jason Curtis, who has served as interim CFO since April 24...
08-14 19:47
美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
美股大行评级 | 最高400美元！亚马逊绩后获11家大行上调目标价；苹果绩后评级分歧大！3家上调，3家下调；德康医疗、万事达、神经分泌生物科学获多家大行上调目标价
今日重点评级关注：TD Cowen：维持加拿大鹅"买入"评级，目标价从13美元升至18美元；瑞银：维持吉登运动服"买入"评级，目标价从110美元升至111美元
08-03 11:38
Keybanc Maintains Overweight on Omnicell, Lowers Price Target to $65
Keybanc analyst Scott Schoenhaus maintains Omnicell (NASDAQ:OMCL) with a Overweight and lowers the price target from $70 to $65.
07-31 20:07
Omnicell shares are trading lower. The company reported Q2 financial results and issued Q3 guidance below analyst estimates.
Omnicell shares are trading lower. The company reported Q2 financial results and issued Q3 guidance below analyst estimates.
07-30 22:32
Omnicell Raises FY2026 Adj EPS Guidance from $1.80-$2.00 to $2.15-$2.30 vs $1.94 Est; Narrows FY2026 Sales Guidance from $1.215B-$1.255B to $1.225B-$1.245B vs $1.248B Est
Omnicell (NASDAQ:OMCL) raises FY2026 Adj EPS guidance from $1.80-$2.00 to $2.15-$2.30 vs $1.94 analyst estimate. Narrows FY2026 sales outlook from $1.215 billion-$1.255 billion to $1.225 billion-$1.245 billion vs $1.248 billion estimate.
07-30 18:40
Omnicell任命Nnamdi Njoku为总裁
医疗保健技术提供商Omnicell（纳斯达克代码：OMCL）宣布，任命Nnamdi Njoku为公司总裁。Njoku自2024年10月起担任Omnicel...
07-01 21:59
Omnicell Appoints COO Nnamdi Njoku As President, Effective July 1
Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell" or the "Company"), a leading healthcare technology provider focused on empowering autonomous medication management, today announced that Nnamdi Njoku has been appointed President of the Company, effective July 1, 2026. Mr. Njoku will retain his role of Chief ...
07-01 20:16
期权交易者是否知晓我们未掌握的Omnicell股票相关信息
欧姆尼科尔公司（Omnicell, Inc.，股票代码：OMCL）出现期权异动，2026年8月21日到期、行权价为65美元的看涨期权，为当日全市场股票期权中隐含...
06-24 23:45
Omnicell（OMCL）或很快触底，为何现在应买入该股票
奥姆尼赛尔公司（Omnicell，OMCL）股价过去两周跌6.3%，但最近一个交易日形成锤形图形态，或意味着获支撑，未来可能趋势反转。 锤形图是蜡烛图常见价格形...
06-15 15:11
